Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders??? Equity (Deficit) (Unaudited)

v3.22.1
Condensed Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Series A
Preferred Stock
Series B
Preferred Stock
Series C
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 1 $ 29,758 $ (36,530) $ (6,771)
Balance (in Shares) at Dec. 31, 2020       7,599,716      
Issuance of common stock warrants in connection with SLOC            
Issuance of common stock and warrants, net of fees 19,326 19,326
Issuance of common stock and warrants, net of fees (in Shares)       4,772,500      
Issuance of common stock and preferred stock in connection with conversion of notes 19,222 19,222
Issuance of common stock and preferred stock in connection with conversion of notes (in Shares) 251 1,443 500,756 1,261,277      
Repurchased beneficial conversion feature in connection with conversion of notes payable (6,647) (6,647)
Issuance of common stock warrants in connection with note exchange agreements 4,918 4,918
Exercise of common stock warrants 180 180
Exercise of common stock warrants (in Shares)       219,199      
Issuance of common stock to consultants 3 3
Issuance of common stock to consultants (in Shares)       693      
Stock-based compensation 3,463 3,463
Stock-based compensation (in Shares)       1,038,095      
Stock option exercise
Stock option exercise (in Shares)       25,000      
Canceled restricted stock awards
Canceled restricted stock awards (in Shares)       (60,000)      
Reclassification of warrant liabilities 3,566 3,566
Net loss (20,672) (20,672)
Balance at Mar. 31, 2021 $ 1 73,789 (57,203) 16,587
Balance (in Shares) at Mar. 31, 2021 251 1,443 500,756 14,856,480      
Balance at Dec. 31, 2021       $ 1 82,677 (73,690) 8,988
Balance (in Shares) at Dec. 31, 2021 251 1,443 500,756 14,530,126      
Delivery of restricted common stock
Delivery of restricted common stock (in Shares)       33,332      
Issuance of common stock warrants in connection with SLOC 223 223
Stock-based compensation 1,083 1,083
Net loss   (4,570) (4,570)
Balance at Mar. 31, 2022 $ 1 $ 83,983 $ (78,260) $ 5,724
Balance (in Shares) at Mar. 31, 2022 251 1,443 500,756 14,563,458